Similar articles

• [Surgical treatment of subserosal fibroids: the cons].

  Marret H, Ouldamer L. Marret H, et al. Gynecol Obstet Fertil. 2011 Jul-Aug;39(7-8):454-7. doi: 10.1016/j.gyobfe.2011.05.012. Epub 2011 Jul 12. Gynecol Obstet Fertil. 2011. PMID: 21752689 French. No abstract available.
• [Possibilities to use the aromatase inhibitors for the treatment of the uterine fibroids].

  Persín J. Persín J. Ceska Gynekol. 2006 Mar;71(2):146-9. Ceska Gynekol. 2006. PMID: 16649417 Review. Czech.
• A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status.

  Parsanezhad ME, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, Frank V, Schmidt EH. Parsanezhad ME, et al. Fertil Steril. 2010 Jan;93(1):192-8. doi: 10.1016/j.fertnstert.2008.09.064. Epub 2009 Jan 9. Fertil Steril. 2010. PMID: 19135657 Clinical Trial.
• Aromatase inhibitors: potential reproductive implications.

  Bedaiwy MA, Mousa NA, Casper RF. Bedaiwy MA, et al. J Minim Invasive Gynecol. 2009 Sep-Oct;16(5):533-9. doi: 10.1016/j.jmig.2009.05.009. Epub 2009 Jul 15. J Minim Invasive Gynecol. 2009. PMID: 19608462 Review.
• Fibroids (uterine myomatosis, leiomyomas).

  Lethaby A, Vollenhoven B. Lethaby A, et al. Clin Evid. 2004 Dec;(12):2563-85. Clin Evid. 2004. Update in: Clin Evid. 2005 Dec;(14):2264-82. PMID: 15865807 Updated. Review. No abstract available.